Carregant...
Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma
Concomitant deregulation of MYC and BCL2 comprises clinically significant, yet poorly characterized biological high-risk feature in diffuse large B-cell lymphoma (DLBCL). To interrogate these lymphomas, we analyzed translocations and protein expression of BCL2, BCL6, and MYC; correlated the findings...
Guardat en:
| Publicat a: | Blood Adv |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7422114/ https://ncbi.nlm.nih.gov/pubmed/32780847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001727 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|